Davidson Michael H. 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Davidson Michael H.（CIK 1573785）在 1 家公司共报告 15 笔 SEC Form 4 内部人交易（最近一笔 2026-09-15）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-15 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Executive Officer | 买入 | 10,000 | $226,500 |
| 2026-03-02 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Executive Officer | 买入 | 443,707 | $0 |
| 2026-03-02 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Executive Officer | 卖出 | 443,707 | $14.8M |
| 2026-02-26 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Executive Officer | 买入 | 64,708 | $0 |
| 2026-02-26 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Executive Officer | 卖出 | 61,547 | $2.2M |
| 2026-02-26 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Executive Officer | 卖出 | 3,161 | $115,250 |
| 2026-02-26 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Executive Officer | 买入 | 58,253 | $0 |
| 2026-02-26 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Executive Officer | 卖出 | 46,517 | $1.6M |
| 2026-02-26 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Executive Officer | 卖出 | 10,436 | $375,279 |
| 2026-02-26 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Executive Officer | 卖出 | 1,300 | $47,684 |
| 2026-02-26 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Executive Officer | 买入 | 183,332 | $0 |
| 2026-02-26 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Executive Officer | 卖出 | 165,408 | $5.6M |
| 2026-02-26 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Executive Officer | 卖出 | 17,924 | $617,303 |
| 2026-01-09 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Executive Officer | 买入 | 81,000 | $0 |
| 2026-01-09 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Executive Officer | 卖出 | 11,582 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-15